The later rise in GH levels is postulated to be due to a decline in somatostatinergic tone plus a reciprocal increase in GHRH, leading to a rebound rise (397)
Talk to a healthcare practitioner before use if you are pregnant or breastfeeding, take medications, have a chronic health condition, or are receiving medical treatments
Dosing typically begins at a lower dose, suggested initiation of 4 units (0.04 mL) weekly for the first 4 weeks, then escalates according to a titration schedule: Weeks 1-4: Inject 4 units (0.04 mL) one time per week Weeks 5-8: Inject 8 units (0.08 mL) one time per week Weeks 9-12: Inject 18 units (0.18 mL) one time per week Weeks 13-16: Inject 30 units (0.3 mL) one time per week Week 16+: Inject 44 units (0.44 mL) one time per week Dosing may deviate from this pattern to accommodate patient-specific needs
None of these include peptides
The integration of peptide therapies like Epithalon into clinical practice requires careful consideration of individual patient factors, thorough informed consent processes, and ongoing monitoring for both efficacy and safety